Advertisement

Topics

Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

04:21 EDT 22 Jun 2017 | Forbes

This morning, Novartis, the Swiss drug giant, announced that a drug that targets inflammation prevented heart attacks and strokes. It could be a scientific breakthrough, and a commercial one, too.

Original Article: Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

NEXT ARTICLE

More From BioPortfolio on "Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...